Neonatal abstinence syndrome happens when a baby has withdrawal after exposure to certain substances during pregnancy, most often opioids. Many people first hear about neonatal abstinence syndrome when a newborn is hard to soothe, feeds poorly, shakes, or has trouble sleeping. Early symptoms of neonatal abstinence syndrome usually begin in the first few days after birth, but timing can vary with the substance involved. Neonatal abstinence syndrome affects newborns, and most babies improve over days to weeks with quiet care, skin-to-skin contact, feeding support, and sometimes medicine. The outlook is often good with treatment, but severe cases can be serious and need close hospital monitoring.
How many people live with Neonatal abstinence syndrome?
Because neonatal abstinence syndrome is a short-term withdrawal condition in newborns, experts usually count how many babies are born with it each year rather than how many people are living with it overall, and there is no single reliable worldwide total because countries do not define and track it the same way. In the United States, it was about 24,000 babies in 2020, based on an estimated 6.7 cases for every 1,000 hospital births (National Institute on Drug Abuse, 2024).
Overview
Neonatal abstinence syndromeSymptoms
Neonatal abstinence syndrome can cause tremors, high-pitched crying, poor feeding, vomiting, diarrhea, and trouble sleeping. Early symptoms of neonatal abstinence syndrome may also include sweating, a stuffy nose, fast breathing, or seizures in severe cases.
Outlook and prognosis
With prompt treatment, many babies with neonatal abstinence syndrome improve over days to weeks and go on to feed, grow, and develop well. Outlook depends on withdrawal severity, overall health, and steady follow-up after discharge.
Causes and risk factors
Neonatal abstinence syndrome usually happens after opioid exposure before birth. Risk rises with higher or longer use during pregnancy, especially near delivery. Other substances, smoking, certain prescribed medicines, and limited prenatal care can worsen symptoms.
Genetic influences
Genetics may slightly affect how strongly Neonatal abstinence syndrome develops, including how severe symptoms are and how long treatment may be needed. But exposure during pregnancy is the main driver, and genetic differences are only one small part of the picture.
Diagnosis
Doctors diagnose neonatal abstinence syndrome by reviewing pregnancy and medication exposure, watching for typical withdrawal signs, and using scoring tools over time. Tests such as urine, meconium, or umbilical cord samples may help confirm exposure.
Treatment and drugs
Treatment for neonatal abstinence syndrome starts with a quiet, low-stimulation setting, swaddling, and frequent feeds. Babies with stronger withdrawal may need medicines such as morphine or methadone, slowly reduced over time. Hospital teams also watch weight gain, hydration, and breathing closely.
Symptoms
Newborns with neonatal abstinence syndrome can seem hard to settle, feed poorly, or have shaking and stomach upset in the first days after birth. The symptoms happen because the baby is adjusting after being exposed to certain substances during pregnancy, most often opioids. Early symptoms of neonatal abstinence syndrome can begin within hours to a few days, though timing depends on the substance involved. Symptoms vary from person to person and can change over time.
Babies with neonatal abstinence syndrome may shake, seem jittery, or have unusually tight muscles. These movements are often more noticeable when they are startled, touched, or trying to settle.
Crying can sound sharp, intense, and hard to soothe. Day to day, it can feel like the baby is uncomfortable even after feeding, changing, and cuddling.
Many babies have trouble falling asleep or staying asleep for long. What once felt effortless can start to require more energy or focus from caregivers because rest periods are short and broken up.
Feeding may be difficult because sucking is uncoordinated or the baby tires quickly. Some may seem very hungry but still struggle to take in enough milk or formula comfortably.
How people usually first notice Neonatal abstinence syndrome?
Neonatal abstinence syndrome is usually first noticed in the first hours to days after birth, when a newborn seems unusually hard to settle and may cry with a high-pitched, intense sound, shake or tremble, have trouble feeding, or seem to sleep poorly. Many living with neonatal abstinence syndrome also show signs such as vomiting, diarrhea, sweating, sneezing, stuffy nose, fast breathing, or a tight, overactive startle response, which can make routine newborn care feel surprisingly difficult. How neonatal abstinence syndrome is first noticed can vary depending on which substances the baby was exposed to during pregnancy and when the last exposure happened, so some newborns look well at first and then develop clearer withdrawal signs over the next few days.
Types of Neonatal abstinence syndrome
Neonatal abstinence syndrome can look different from one baby to the next, depending on which substances they were exposed to before birth and how much exposure occurred. It can be helpful to think of symptoms in categories. When people ask about the types of neonatal abstinence syndrome, doctors usually mean these symptom patterns rather than separate diseases. Some babies mainly have trouble with calming and sleep, while others have more feeding, stomach, or breathing problems.
Nervous system
This pattern centers on irritability, high-pitched crying, jitteriness, stiff muscles, and trouble settling. A baby may seem hard to soothe, sleep only in short stretches, or startle easily with light or sound. In more severe cases, seizures can happen, but this is less common.
Feeding stomach
Some babies with neonatal abstinence syndrome have poor feeding, weak sucking, vomiting, loose stools, or trouble gaining weight. In daily life, this can mean long, difficult feeds followed by spitting up or hunger again soon after. These symptoms can raise the risk of dehydration if they are strong.
Autonomic signs
This type affects automatic body functions, leading to sweating, fever, sneezing, yawning, mottled skin, or temperature instability. A baby may feel clammy, seem too warm or too cool, or have frequent sneezing without an infection. These signs often happen alongside other symptom types rather than alone.
Breathing sleep
Some newborns show faster breathing, nasal stuffiness, and poor sleep, with only brief periods of rest between feeds and crying. One type may be strong for a while, then fade as another emerges. Because breathing problems can also have other causes, clinicians look at the whole pattern rather than one sign by itself.
Can I slow down the onset of symptoms?
Not in a proven, reliable way: neonatal abstinence syndrome is withdrawal in a newborn after exposure to opioids or some other drugs during pregnancy, and once that exposure has happened, there is no well-established lifestyle change that meaningfully delays the start of symptoms. The most helpful steps are earlier in pregnancy or before birth, such as regular prenatal care, treatment for opioid use under medical supervision, avoiding nicotine, alcohol, and non-prescribed drugs, and breastfeeding when it is safe and recommended, because these may lower the baby’s overall risk or make symptoms milder, but they do not prevent the condition. If a baby is known to have been exposed, doctors usually watch closely after birth so care can start quickly, and while that cannot guarantee a later onset or no symptoms, it can still make a real difference in how well the baby does.
What genetics can tell you about symptoms
Genetics may help explain why some babies exposed to opioids during pregnancy have more noticeable withdrawal symptoms than others, even when the exposure seems similar. Studies suggest that small genetic differences in the baby, and sometimes the birth parent, can affect how likely symptoms are to appear, how severe they are, and whether treatment is needed, but these links are not strong enough to predict exactly what any one baby will experience. In neonatal abstinence syndrome, symptoms are still shaped by many other factors too, including which medicines were used, the dose, timing during pregnancy, smoking, and whether the baby was born early or full term.
Causes and risk factors
The main cause of neonatal abstinence syndrome is opioid exposure during pregnancy, including prescribed pain medicines and nonmedical opioid use. Risk can also rise with some other medicines, such as certain sleeping pills or antidepressants, especially when more than one substance is involved. Using tobacco, alcohol, or other drugs during pregnancy can make neonatal abstinence syndrome more likely or more severe. A baby's gestational age and the timing of the last exposure before birth also matter, and they can shape the early symptoms of neonatal abstinence syndrome. Inherited differences may also affect how strongly a baby reacts, but researchers are still learning how these pieces fit together.
What are the most common causes or risk factors?
Neonatal abstinence syndrome most often happens when a baby is exposed during pregnancy to opioids, which are strong pain drugs, including prescription pain medicines, heroin, or medicines used to treat opioid use disorder, and then goes through withdrawal after birth. The risk is often higher when exposure lasts longer, the amount is higher, the drug is used closer to delivery, or other substances such as nicotine, alcohol, sleeping pills, or some antidepressants are also involved. Genes may slightly affect how strong a baby’s symptoms are, but the main causes and risk factors are drug exposure during pregnancy, especially opioid exposure and use of more than one substance.
Environmental and biological risk factors
Neonatal abstinence syndrome happens when a baby has withdrawal after being exposed to certain substances before birth, most often opioids. The main risk factors for neonatal abstinence syndrome are the type of substance, how much and how long the exposure lasted, and whether other medicines were also involved. Doctors often group risks into internal (biological) and external (environmental).
Exposure to opioids during pregnancy is the strongest risk factor for neonatal abstinence syndrome. This includes prescription opioid pain medicines as well as methadone, buprenorphine, heroin, and fentanyl. Regular exposure can make withdrawal after birth more likely.
Longer-acting opioids often lead to withdrawal that starts later and can last longer. Methadone and buprenorphine are common examples. Babies exposed to these medicines may need close monitoring after delivery.
Higher total exposure and exposure over more of the pregnancy can increase the chance and severity of neonatal abstinence syndrome. A baby exposed repeatedly over weeks or months is more likely to become physically dependent before birth.
When exposure continues into the last days or weeks before delivery, withdrawal is more likely to appear soon after birth. This is because the baby is still receiving the substance through the placenta right up to delivery.
Genetic risk factors
Neonatal abstinence syndrome can be more severe in some newborns partly because of inherited differences in how the baby and pregnant parent respond to certain medicines. There is no single gene that causes neonatal abstinence syndrome, and genes do not fully predict who will have symptoms or how strong they will be. Risk is not destiny—it varies widely between individuals. The best-studied genetic risk factors for neonatal abstinence syndrome involve opioid signaling and the body’s drug-processing pathways.
No single gene: Neonatal abstinence syndrome is not inherited in a simple one-gene pattern. Instead, several genetic differences may slightly raise or lower the chance of stronger withdrawal symptoms.
Baby’s genes: A newborn’s own genes can affect how the brain and nervous system react after birth. This may help explain why symptoms are mild in some babies and more intense in others.
Parent’s genes: Genes in the pregnant parent can influence how certain medicines are broken down and how much reaches the baby. These inherited differences may partly change risk, but they cannot predict the outcome by themselves.
Opioid receptor gene: Changes in the OPRM1 gene, which helps the body respond to opioids, have been linked in some studies to differences in symptom severity. This gene seems to affect risk rather than act as a direct cause.
COMT pathway: Variants in COMT and related stress-response pathways may also shape how severe withdrawal symptoms become. Study results have not always matched, so doctors do not use this gene alone to forecast symptoms.
Drug-processing genes: Inherited differences in drug-processing enzymes can change how quickly opioids are handled by the parent and baby. This is one reason people ask whether neonatal abstinence syndrome can be inherited, but genes mainly influence susceptibility and severity rather than fully determining the condition.
Lifestyle risk factors
For neonatal abstinence syndrome, the main lifestyle-related risks come from substance use patterns during pregnancy. When people ask about lifestyle risk factors for neonatal abstinence syndrome, they are usually referring to behaviors that increase fetal exposure to opioids or other substances and make withdrawal after birth more likely or more severe. The type of substance, how often it is used, and whether several substances are used together all matter. Early prenatal care and treatment for substance use can reduce risk and improve newborn outcomes.
Using opioids during pregnancy is the strongest lifestyle-related driver of neonatal abstinence syndrome. Higher doses, daily use, and longer exposure during pregnancy can increase the chance and severity of withdrawal in the newborn.
Combining opioids with benzodiazepines, stimulants, nicotine, or some sedating medicines can make neonatal withdrawal more complex. Babies exposed to multiple substances may have more feeding problems, irritability, sleep disruption, or need longer monitoring after birth.
Cigarette smoking during pregnancy is linked to worse neonatal abstinence syndrome in opioid-exposed infants. Nicotine exposure can increase withdrawal severity and may raise the need for medication treatment after delivery.
Alcohol use during pregnancy can add to neurologic and feeding difficulties in the newborn. When it occurs alongside opioid exposure, it can complicate how lifestyle affects neonatal abstinence syndrome and make recovery less predictable.
Risk prevention
Neonatal abstinence syndrome happens when a baby develops withdrawal after exposure to certain substances during pregnancy, most often opioids. The best way to lower the risk of neonatal abstinence syndrome is to get early prenatal care and work with a clinician before making any changes to medicines or substance use. Prevention isn’t about perfection, it’s about small steps that add up. In some pregnancies, medicine cannot be fully avoided, so prevention may also mean safer treatment, close monitoring, and planning for the baby’s care after birth.
Starting prenatal care as early as possible gives you and your care team time to review medicines, substance use, and other health needs. Regular visits can lower the risk of neonatal abstinence syndrome by helping problems get noticed and managed sooner.
If you take opioids, do not stop suddenly on your own during pregnancy because this can be risky for both you and the baby. A clinician can help taper a medicine when appropriate or switch to a safer, structured treatment plan.
For opioid use disorder, evidence-based treatment during pregnancy can reduce harmful drug use and improve pregnancy outcomes. This often includes medication treatment, counseling, and practical support to help lower the chance of severe neonatal abstinence syndrome.
Alcohol, nicotine, benzodiazepines, and some other drugs can worsen withdrawal in newborns or add other health risks. Let your prenatal team know about everything you take, including prescriptions, over-the-counter products, and supplements.
Can you prevent Neonatal abstinence syndrome?
Neonatal abstinence syndrome, which means withdrawal symptoms in a newborn after exposure to certain medicines or drugs during pregnancy, cannot always be fully prevented, but the risk can often be lowered. The clearest ways to reduce the risk are getting regular pregnancy care, avoiding non-prescribed opioids and other habit-forming drugs, and, if these medicines are needed, working closely with a doctor on the safest plan instead of stopping suddenly. Even with good care, some babies may still develop it.
Transmission
Neonatal abstinence syndrome is not an infection, so it is not contagious and cannot spread from one baby to another through touch, coughing, shared spaces, or routine contact. When people ask how neonatal abstinence syndrome is transferred, the key point is that the syndrome itself is not passed between people.
Instead, neonatal abstinence syndrome happens when a baby is exposed during pregnancy to certain substances, most often opioids, and then develops withdrawal after birth when that exposure suddenly stops. The chance of this happening depends on the type of substance, the dose, how long it was used, and when in pregnancy the exposure occurred.
When to test your genes
For neonatal abstinence syndrome, genetic testing is not routinely used for early detection or to guide treatment. What matters most is the pregnancy exposure history, the baby’s symptoms after birth, and careful medical monitoring. Genes may be studied in research, but they are not part of standard care.
Diagnosis
Neonatal abstinence syndrome is usually diagnosed after a baby shows withdrawal signs in the first hours to days after birth, such as tremors, feeding trouble, a high-pitched cry, poor sleep, or diarrhea. Doctors use the baby’s symptoms together with the pregnancy and medication history to understand whether opioid or other substance exposure may be the cause. It’s natural to worry when symptoms don’t have a clear explanation. In practice, the diagnosis of neonatal abstinence syndrome is based on careful observation and tests that help rule out other problems in a newborn.
Doctors watch for patterns such as shaking, irritability, stiff muscles, sweating, vomiting, loose stools, and trouble feeding or settling. They also note when symptoms begin and how severe they are, since timing can help link them to substance exposure before birth.
A detailed family and health history can help, especially information about prescribed pain medicines, treatment for opioid use disorder, nicotine, antidepressants, or other substances used during pregnancy. This history is important because neonatal abstinence syndrome can look different depending on what the baby was exposed to.
Many hospitals use a structured scoring system or a functional assessment to track withdrawal signs over time. These tools help the care team judge how neonatal abstinence syndrome is progressing and whether the baby needs closer monitoring or treatment.
Doctors examine the baby for dehydration, weight loss, fever, breathing problems, skin changes, and signs of poor feeding. The exam also helps identify other causes of similar symptoms, including infection or low blood sugar.
How is Neonatal abstinence syndrome diagnosed?
Neonatal abstinence syndrome is diagnosed by looking at the baby’s symptoms after birth and asking whether there was exposure to opioids or certain other medicines or drugs during pregnancy. Doctors and nurses watch for a pattern of withdrawal signs, such as high-pitched crying, shaking, poor feeding, trouble sleeping, vomiting, diarrhea, or breathing problems, and they often use a simple scoring checklist over time to see how severe the symptoms are. There is no single test that proves it, but urine, stool from the baby’s first bowel movement, or umbilical cord testing may help confirm exposure and rule out other causes.
Stages of Neonatal abstinence syndrome
Neonatal abstinence syndrome does not have defined progression stages. This is because it is usually a withdrawal problem that appears in the first hours to days after birth, rather than a condition that moves through clear step-by-step phases over time. Often the process begins when you notice changes in daily life, such as a baby feeding poorly, crying with a high-pitched sound, shaking, or having trouble settling, which can be early symptoms of neonatal abstinence syndrome. Doctors usually diagnose and monitor neonatal abstinence syndrome by looking at symptoms, checking how the baby is feeding, sleeping, and breathing, and reviewing medication or substance exposure during pregnancy.
Outlook and prognosis
The outlook for infants with neonatal abstinence syndrome is generally good when the condition is recognized early and treated with supportive care and, when needed, medication. Most newborns recover over days to weeks, although some need longer hospital stays, especially after exposure to long-acting opioids or multiple substances during pregnancy. Severe complications such as seizures, feeding problems, dehydration, poor weight gain, and breathing difficulties can occur, but death from neonatal abstinence syndrome itself is uncommon in modern medical care. Long-term prognosis is more variable and depends not only on withdrawal severity but also on prematurity, polysubstance exposure, prenatal care, and the child’s home environment after discharge. Some studies suggest higher risks of developmental, behavioral, and learning difficulties later in childhood, but it is often difficult to separate the effects of withdrawal from other medical and social factors. Careful follow-up, early intervention services, and a stable caregiving environment can substantially improve outcomes.
Long-term effects
Many babies with neonatal abstinence syndrome improve over days to weeks, but some may have health or developmental effects that show up later in infancy and childhood. The long-term picture is often shaped by several things at once, including how severe withdrawal was, whether the baby was born early, and other prenatal exposures. For many, this can mean closer follow-up for feeding, growth, behavior, and development as they get older. Research on the long-term effects of neonatal abstinence syndrome is still growing, so outcomes can vary widely from child to child.
Some children with neonatal abstinence syndrome may reach motor, language, or learning milestones later than expected. This can show up as slower sitting, walking, talking, or more trouble with school-readiness skills in early childhood.
Attention problems, high activity levels, and difficulty settling can be more common in some children who had neonatal abstinence syndrome. Many living with these challenges may seem unusually impulsive or have a harder time with routines at home or in preschool.
Sleep can stay unsettled for a while, even after the newborn period has passed. Some may wake often, nap poorly, or have trouble calming, which can affect daily routines for the whole family.
Early feeding problems can sometimes carry over into slow weight gain or growth concerns. A baby who tires easily during feeds or spits up often may need closer monitoring over time.
How is it to live with Neonatal abstinence syndrome?
Living with neonatal abstinence syndrome means starting life with a nervous system that is on high alert, so babies may be hard to soothe, feed poorly, sleep in short stretches, and cry with an intensity that can be exhausting for everyone nearby. Daily life often revolves around careful feeding, swaddling, skin-to-skin contact, frequent medical follow-up, and watching for steady weight gain and comfort; for many infants, symptoms improve over days to weeks, although some need longer support. For parents and other caregivers, this can mean disrupted sleep, stress, guilt, and many appointments, but with calm routines, medical care, and family support, many babies recover well and settle into more typical patterns over time.
Treatment and drugs
Neonatal abstinence syndrome is treated by helping a newborn stay comfortable, feed well, sleep, and gain weight while the body adjusts after exposure to certain medicines or drugs during pregnancy. Treatment often starts with a calm, low-stimulation setting, swaddling, skin-to-skin contact, and frequent small feeds, since many babies with neonatal abstinence syndrome are fussy, shake, have trouble settling, or burn extra energy while feeding. If symptoms are more severe, doctors may use medicines such as morphine or methadone and then slowly lower the dose over days to weeks, and some babies may also need extra treatment for diarrhea, poor weight gain, or dehydration. Treatment often looks different for each person, and for neonatal abstinence syndrome it depends on how strong the symptoms are, what substances were involved, and whether the baby was born early or has other medical needs. Most babies improve with careful monitoring and supportive care, but they usually need close follow-up after leaving the hospital.
Can you cure Neonatal abstinence syndrome?
There is not a quick cure for neonatal abstinence syndrome, but it is usually temporary and most babies get better with time and careful treatment. Treatment focuses on easing withdrawal symptoms with a calm, quiet setting, close comforting, regular feeding, and sometimes medicine that is slowly reduced over days or weeks.
Non-drug treatment
Caring for a baby with neonatal abstinence syndrome often centers on keeping the environment calm, helping with feeding, and supporting sleep and comfort while withdrawal symptoms ease. In day-to-day life, this can mean a baby who startles easily, cries hard to settle, or tires quickly during feeds, so non-drug care is often the first step and may continue even if medicine is needed. Non-drug treatments often lay the foundation for recovery and can reduce stress for both the baby and caregivers. Not every approach works the same way, so the care plan is usually adjusted to the baby’s symptoms and feeding needs.
Keeping the baby in the same room as a parent or caregiver can lower stress and help staff respond quickly to cues. Many living with neonatal abstinence syndrome settle better with this close, steady contact than with frequent separation.
A quiet room with dim light and less noise can help reduce trembling, irritability, and trouble settling. You might notice the baby feeds or sleeps a little better when there is less stimulation.
Skin-to-skin holding can support bonding, temperature control, and calmer breathing and heart rate. For many, treatment begins not at the pharmacy, but with simple comfort steps like holding the baby close and responding early to distress.
Swaddling, gentle rocking, and paced comforting can help a baby who is fussy, stiff, or easily startled. These hands-on approaches are commonly used for the early symptoms of neonatal abstinence syndrome and may reduce the need for medicine in some babies.
Your genes may have an impact on how drugs work for you
In babies with neonatal abstinence syndrome, small inherited differences can affect how their bodies handle medicines used to calm withdrawal symptoms, such as how quickly a drug is broken down or how strongly it works, so some babies may need a lower dose while others need more time or closer dose changes. This kind of gene-and-medicine matching is called pharmacogenomics, but for neonatal abstinence syndrome it is still an emerging area and is not yet a routine part of care in most hospitals. In everyday practice, the care team usually adjusts treatment based on the baby’s symptoms, feeding, sleep, and comfort rather than on genetic testing alone.
Pharmacological treatments
When a newborn has trouble feeding, sleeping, or settling because of withdrawal after birth, medicine may be used if comfort measures alone are not enough. In neonatal abstinence syndrome, the main goal of treatment is to ease withdrawal symptoms safely, support feeding and growth, and then slowly reduce the medicine over time. First-line medications are those doctors usually try first, based on the baby’s symptoms and the drug exposure during pregnancy.
Morphine is one of the most commonly used medicines for neonatal abstinence syndrome, especially when opioid withdrawal signs are strong. It can help with shaking, irritability, poor sleep, and trouble feeding. The dose is usually tapered gradually as the baby becomes more settled.
Methadone is another standard opioid medicine used to treat withdrawal in newborns. It works in a similar way to morphine but lasts longer in the body, which can make dosing schedules simpler in some babies. Many living with neonatal abstinence syndrome need careful monitoring while the dose is slowly reduced.
Buprenorphine is used in some hospitals as an alternative to morphine or methadone. Early studies suggest it may shorten treatment time for some babies, but it is not yet used everywhere. Not every baby responds to the same medication in the same way.
Phenobarbital may be added when a baby has severe jitteriness, trouble settling, or exposure to more than one substance. It can be especially helpful when opioid treatment alone does not control symptoms well. Because it can cause sleepiness, the care team watches feeding and alertness closely.
Genetic influences
The early symptoms of neonatal abstinence syndrome can look quite different from one newborn to another, even when the pregnancy exposure seems similar. Research on genetic factors in neonatal abstinence syndrome suggests that small inherited differences in how a baby’s body responds to opioids and stress, and how the birth parent’s body processes these substances, may affect how severe symptoms become. Genetics is only one piece of the puzzle, though; the type of substance, the amount used, when it was used during pregnancy, smoking, and whether the baby is born early can all matter a great deal. This means neonatal abstinence syndrome is not usually passed down in a simple yes-or-no way, and family history alone cannot predict which newborns will need the most treatment. Studies are still developing, so genetic testing is not a routine part of diagnosing or treating neonatal abstinence syndrome.
Is Neonatal abstinence syndrome genetic?
Genetics may slightly affect how strongly Neonatal abstinence syndrome develops, including how severe symptoms are and how long treatment may be needed. But exposure during pregnancy is the main driver, and genetic differences are only one small part of the picture.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are found throughout the general population. Most of these variants do not directly affect health and simply reflect natural differences among people. For many genes, having a variant that is linked to a condition suggests a possible association, not a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-understood variant in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When babies with neonatal abstinence syndrome need medicine, even small differences in how their bodies handle a drug can matter. Research suggests that inherited differences in genes linked to opioid response and drug breakdown may affect how strong withdrawal symptoms are and why some babies with neonatal abstinence syndrome need longer treatment than others. Genes can influence how quickly the body processes medicine, so some infants may need dose changes sooner or later than expected when medicines such as morphine or methadone are used. Even so, genetic testing is not a routine part of care for neonatal abstinence syndrome, because doctors still learn the most by watching feeding, sleep, weight gain, breathing, and withdrawal signs day by day. Other factors, including the type and timing of opioid exposure during pregnancy and the baby’s overall health, also shape treatment response. In practice, care is usually adjusted step by step, with medicine and supportive comfort measures tailored to how the baby is doing.
Interactions with other conditions
Neonatal abstinence syndrome can be harder to sort out when a newborn also has another medical problem, because signs like jitteriness, feeding trouble, vomiting, poor sleep, or fast breathing can look similar to other illnesses. Doctors call it a “comorbidity” when two conditions occur together. In practice, infections, low blood sugar, breathing problems, and seizures can mimic or worsen symptoms, so babies often need careful monitoring to make sure nothing important is missed. Premature babies may show neonatal abstinence syndrome differently, and issues linked with prematurity, such as trouble keeping warm or feeding well, can add to the picture. Some infants are also born smaller than expected or have been exposed to nicotine or other substances during pregnancy, which can make withdrawal seem more intense or make recovery take longer. Because of this overlap, the early symptoms of neonatal abstinence syndrome are usually assessed alongside other possible causes so treatment fits the whole baby, not just the withdrawal.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Neonatal abstinence syndrome?
Several newborn problems can look like neonatal abstinence syndrome, including a serious infection, low blood sugar, or low calcium, because all of these can cause shaking, fussiness, trouble feeding, or seizures. Doctors may also check for brain problems linked to a difficult birth, such as bleeding or too little oxygen, and for effects from other medicines used during pregnancy, including some antidepressants. That is why the care team usually looks at pregnancy and medicine history, does an exam, and may order a few blood tests before deciding the symptoms are due to withdrawal.
History
Doctors began describing babies who were unusually irritable, feeding poorly, trembling, or having trouble settling soon after birth well over a century ago. What we now call neonatal abstinence syndrome was first recognized when clinicians noticed that some newborns developed withdrawal symptoms after exposure to opioids during pregnancy. In early reports from the late 1800s and early 1900s, these babies were described mainly by what people could see day to day: constant crying, vomiting, sweating, diarrhea, and difficulty sleeping.
As medical science evolved, neonatal abstinence syndrome became better understood as a pattern rather than a collection of isolated symptoms. This mattered because the condition can look different from one baby to another. One newborn might seem hard to console and feed every hour, while another may have loose stools, shaky movements, and trouble gaining weight. Over time, doctors learned that the timing and severity of symptoms can vary depending on the type of exposure, how long it lasted, and the baby’s overall health.
A major step forward came in the 20th century, especially as opioid use changed and more babies were born after prenatal exposure to medicines such as methadone as well as other opioids. Researchers and hospital teams began creating clearer ways to recognize the early symptoms of neonatal abstinence syndrome and decide when treatment was needed. In the 1970s, scoring systems were introduced to track signs such as tremors, poor feeding, and sleep problems more consistently, helping nurseries and neonatal units compare symptoms over time and respond more systematically.
The history of neonatal abstinence syndrome also reflects changes in language and attitudes. Earlier medical writing often focused narrowly on drug exposure, with much less attention to family support, maternal health, or the stress of caring for a newborn with prolonged withdrawal. In recent decades, awareness has grown that care works best when it supports both the baby and the parent, using quiet rooms, skin-to-skin contact, feeding support, and keeping families involved whenever possible.
Today, neonatal abstinence syndrome is recognized more accurately than it was in the past, and medical teams have a much better sense of which babies need close monitoring after birth. Even so, the history of the condition is a reminder that better observation, more respectful language, and family-centered care can change outcomes in very practical ways. For many living through this experience, that means faster recognition, gentler treatment, and more support during a stressful first stretch of life.